Venture Capital

Pershing Square's latest share repurchase is more than routine; it's a strategic move to close a stubborn valuation gap and signal deep confidence.

A monumental $31.5 billion contract tasks Peraton with replacing the FAA's aging air traffic control system. Can it succeed where others have failed?

A key accelerator selection puts South Korean startup ALL CONEC and its AI-driven dental platform in the spotlight, backed by Oracle's cloud power.

With new funding, Japan's Helical Fusion is racing to build a fusion plant by the 2030s. Can its unique stellarator technology win the clean energy race?

With a clear FDA path for its breakthrough drug, Praxis is set to disrupt the stagnant, multi-billion-dollar essential tremor market.

After its DMD drug trial sent shares soaring over 370%, Capricor Therapeutics is raising $75M. A look at the high-stakes strategy to fund a breakthrough.

Immunome is using strategic stock grants to lure top talent. We analyze why this move is critical for its pipeline and what it means for investors.

Virax secured a $5M runway for its Long COVID diagnostics, but the deal's terms reveal a high-stakes gamble involving significant shareholder dilution.

A new partnership between Pellera Technologies and the NY Rangers is more than a sponsorship. It's a strategic play on heritage, B2B marketing, and community.

How Winemaker of the Year Jesse Katz blends record-setting sales, historic vineyards, and philanthropy to disrupt the ultra-premium wine market.

A new book on stuttering highlights a growing trend: using storytelling as a powerful, low-tech innovation to foster empathy and address childhood health.

An IT giant's partnership with the NY Rangers is more than ads. It's a masterclass in post-merger branding and a look at the future of B2B marketing.

With AI creating a data center power crisis, one company's safer, greener nickel-zinc batteries are attracting major investment. Here's why it matters.

An award-winning conservation group is turning holiday shopping into a revenue stream for reef restoration. Is this the future of environmental funding?

The battery innovator secures fresh capital to scale its 'One-Pot' process. We analyze if this move signals a turning point for investors and the EV market.

Lockheed Martin's new AI instantly adapts to mission failures, reducing operator stress and offering a new layer of protection for service members.

A strategic investment and nationwide rollout of SOTA Cloud's imaging platform across 1,000+ practices signal a new era of integrated dental-medical data.

A breakthrough in Houston: Tiny microbes are eating methane waste and turning it into valuable fertilizer, offering a profitable solution to climate change.

A breakthrough stem cell study extends hope for stroke recovery. But a supplement brand is using it to sell 'detox' pills. We separate the facts from fiction.

A routine UK regulatory filing has exposed Arrowstreet Capital's quiet 1.22% stake in the $1.44B American Axle-Dowlais merger, signaling a major quant fund's bet.